Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rodrigo A Fraga-Silva

Showing results (31-40 of 50) with videos related to

Pageof 5
Sort By:
Protein and Peptide Letters|October 14, 2015
Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in RatsMarilda L A De Maria, Liliane D Araújo, Rodrigo A Fraga-Silva, et al.
Atherosclerosis|February 9, 2013
Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE-/- miceVania C Olivon, Rodrigo A Fraga-Silva, Dolf Segers, et al.
Molecular Medicine (Cambridge, Mass.)|January 30, 2010
ACE2 activation promotes antithrombotic activityRodrigo A Fraga-Silva, Brian S Sorg, Mamta Wankhede, et al.
European Journal of Clinical Investigation|December 9, 2016
Alamandine abrogates neutrophil degranulation in atherosclerotic miceAnalina R Da Silva, Sébastien Lenglet, Federico Carbone, et al.
Vascular Pharmacology|August 26, 2015
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient miceRodrigo A Fraga-Silva, Fabrizio Montecucco, Fabiana P Costa-Fraga, et al.
The Journal of Sexual Medicine|November 21, 2014
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injuryRodrigo A Fraga-Silva, Fabiana P Costa-Fraga, Fabrizio Montecucco, et al.
European Journal of Clinical Investigation|January 17, 2018
Apelin-13 treatment enhances the stability of atherosclerotic plaquesRodrigo A Fraga-Silva, Hugo Seeman, Fabrizio Montecucco, et al.
Thrombosis and Haemostasis|July 29, 2016
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesisFabrizio Montecucco, Alexander I Bondarenko, Sébastien Lenglet, et al.
Vascular Pharmacology|April 15, 2015
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic miceAna Luíza Gomes Quinderé, Norma Maria Barros Benevides, Graziano Pelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 10, 2007
Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile functionAndrey C da Costa Gonçalves, Romulo Leite, Rodrigo A Fraga-Silva, et al.
Pageof 5

Showing results (31-40 of 50) with videos related to

Sort By:
Pageof 5
Protein and Peptide Letters|October 14, 2015
Anti-hypertensive Effects of Diminazene Aceturate: An Angiotensin- Converting Enzyme 2 Activator in RatsMarilda L A De Maria, Liliane D Araújo, Rodrigo A Fraga-Silva, et al.
Atherosclerosis|February 9, 2013
Arginase inhibition prevents the low shear stress-induced development of vulnerable atherosclerotic plaques in ApoE-/- miceVania C Olivon, Rodrigo A Fraga-Silva, Dolf Segers, et al.
Molecular Medicine (Cambridge, Mass.)|January 30, 2010
ACE2 activation promotes antithrombotic activityRodrigo A Fraga-Silva, Brian S Sorg, Mamta Wankhede, et al.
European Journal of Clinical Investigation|December 9, 2016
Alamandine abrogates neutrophil degranulation in atherosclerotic miceAnalina R Da Silva, Sébastien Lenglet, Federico Carbone, et al.
Vascular Pharmacology|August 26, 2015
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient miceRodrigo A Fraga-Silva, Fabrizio Montecucco, Fabiana P Costa-Fraga, et al.
The Journal of Sexual Medicine|November 21, 2014
Diminazene protects corpus cavernosum against hypercholesterolemia-induced injuryRodrigo A Fraga-Silva, Fabiana P Costa-Fraga, Fabrizio Montecucco, et al.
European Journal of Clinical Investigation|January 17, 2018
Apelin-13 treatment enhances the stability of atherosclerotic plaquesRodrigo A Fraga-Silva, Hugo Seeman, Fabrizio Montecucco, et al.
Thrombosis and Haemostasis|July 29, 2016
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesisFabrizio Montecucco, Alexander I Bondarenko, Sébastien Lenglet, et al.
Vascular Pharmacology|April 15, 2015
Treatment with sulphated galactan inhibits macrophage chemotaxis and reduces intraplaque macrophage content in atherosclerotic miceAna Luíza Gomes Quinderé, Norma Maria Barros Benevides, Graziano Pelli, et al.
American Journal of Physiology. Heart and Circulatory Physiology|July 10, 2007
Evidence that the vasodilator angiotensin-(1-7)-Mas axis plays an important role in erectile functionAndrey C da Costa Gonçalves, Romulo Leite, Rodrigo A Fraga-Silva, et al.
Pageof 5